SCHEMBL31480591

SCHEMBL31480591

COC(=O)c1ccc(I)cc1NC(=O)OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
CYP1A2 P05177 1/20 0.50
CYP2C19 P33261 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
KDM4E B2RXH2 6/20 0.49
ALDH1A1 P00352 5/20 0.49
GAA P10253 2/20 0.49
HPGD P15428 2/20 0.49
GLA P06280 1/20 0.49
ATM Q13315 1/20 0.49
POLB P06746 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
TACR3 P29371 1/20 0.47
MAOB P27338 1/20 0.46
MGLL Q99685 1/20 0.46
KMT2A Q03164 3/20 0.46
LMNA P02545 2/20 0.46
MEN1 O00255 1/20 0.46
RAF1 P04049 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31480389 0.88 NPC1 (0.55) NPC1RAB9ASMN1; SMN2ALDH1A1ATM
SCHEMBL10874779 0.85 NPC1 (0.68) NPC1RAB9ACYP1A2CYP2C19SMN1; SMN2
SCHEMBL7595080 0.79 MGLL (0.49) NPC1RAB9ACYP1A2CYP2C19SMN1; SMN2
SCHEMBL2276099 0.79 KDM4E (0.66) RAB9ACYP1A2CYP2C19SMN1; SMN2KDM4E
SCHEMBL1095126 0.79 CASP3 (0.58) NPC1RAB9ACYP1A2CYP2C19SMN1; SMN2
SCHEMBL5056843 0.78 CYP2C19 (0.60) NPC1RAB9ACYP1A2CYP2C19SMN1; SMN2
SCHEMBL31480254 0.78 NPC1 (0.46) NPC1RAB9ACYP1A2CYP2C19SMN1; SMN2
SCHEMBL27567788 0.78 CYP1A2 (0.63) NPC1RAB9ACYP1A2CYP2C19SMN1; SMN2
SCHEMBL10192674 0.77 NPC1 (0.64) NPC1RAB9ACYP1A2CYP2C19SMN1; SMN2
SCHEMBL1490611 0.77 NPC1 (0.57) NPC1RAB9ACYP1A2CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025054361-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2025-03-13 WO disclosed